Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Waystar to Announce First Quarter 2025 Financial Results on April 30, 2025
-
UBS Declares Coupon Payments on 12 ETRACS Exchange Traded Notes
-
Enterprise Declares Quarterly Distribution
-
Franklin BSP Realty Trust, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call
-
Concentra® to Announce First Quarter 2025 Results on Wednesday, May 7, 2025
-
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
-
Voya Financial schedules announcement of first-quarter 2025 results
-
Core Scientific Announces March 2025 Production and Operations Updates
-
Independent Bank Corp.’s Announcement of Date of First Quarter Conference Call
-
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
-
HBT Financial, Inc. to Announce First Quarter 2025 Financial Results on April 21, 2025
-
Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL
-
Monthly information on share capital and company voting rights
-
FRO – Filing of Annual Report
-
SOUN Shareholders Should Contact Wolf Haldenstein for Information About Participating in the SoundHound AI, Inc. Class Action
-
VICI Properties Announces Closing of $1.3 Billion Senior Unsecured Notes Offering
-
Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference
-
Defiance ETFs Announces Closure of the Defiance Daily Target 2x Long Uranium ETF (Ticker: URAX)
-
Premier Sotheby’s International Realty Ranked No. 21 in RISMedia’s Top 1,000 Power Broker Report, Leads the Sotheby’s International Realty® Global Network
-
Range Announces Conference Call to Discuss First Quarter 2025 Financial Results
-
Press Ranger Celebrates 8,000 Users, Best PR Software Award
-
John Linton Joins Edmentum as Chief Revenue Officer
-
Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
New Birth Announces 'The Great Awakening' - A Transformative Easter Weekend Celebration, April 18-20
-
Bonterra Announces Closing of Private Placement of Units
-
KWG Resources Inc Announces Closing of First Tranche of Its Private Placement of Units
-
CORRECTION – Presidio Property Trust, Inc. Announces Earnings for the Year Ended December 31, 2024
-
Webster Financial Corporation Announces Q1 2025 Earnings Release and Conference Call
-
T. Marzetti Company Names Tanya Berman Retail President
-
Diversified Healthcare Trust First Quarter 2025 Conference Call Scheduled for Tuesday, May 6th
-
Broadcom Inc. Announces $10 Billion Share Repurchase Authorization
-
EPR Properties First Quarter 2025 Earnings Conference Call Scheduled for May 8, 2025
-
Elme Communities to Release First Quarter 2025 Results on Thursday, May 1st
-
CACI Awarded $66 Million Task Order to Provide Expertise to U.S. Navy Naval Surface Warfare Center (NSWC)
-
Grand Canyon Education, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details
-
Brighthouse Financial Announces Conference Call to Discuss First Quarter 2025 Results
-
Greenbrier announces Second Quarter financial results
-
Assurant to Announce First Quarter 2025 Financial Results
-
C.H. Robinson Announces Dorothy Capers as New Chief Legal Officer and Secretary
-
Goldman Sachs BDC, Inc. Schedules Earnings Release and Conference Call to Announce First Quarter 2025 Results
-
Equity Residential Announces First Quarter 2025 Earnings Release Date
-
Accel Entertainment Names Scott Levin as Chief Legal Officer
-
PayPal Announces Retirement of Rodney C. Adkins from Board of Directors
-
Franklin Street Properties Corp. Declares Quarterly Dividend
-
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2025
-
New Mountain Finance Corporation Schedules its First Quarter 2025 Earnings Release and Conference Call
-
Abacus Global Management Well-Positioned Amid Market Volatility
-
Innventure, Inc. to Announce Fourth Quarter and Full Year 2024 Results on April 11
-
CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)

